Order Article Reprints

Niethard M, Knebel C, Leithner A, Tunn P-U, Schoon J, Reichardt P, Pogkas A, Szkandera J, Pink D, Andreou D. What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor Entity. Cancers. 2024; 16(9):1633. https://doi.org/10.3390/cancers16091633

Niethard, Maya, Carolin Knebel, Andreas Leithner, Per-Ulf Tunn, Janosch Schoon, Peter Reichardt, Athanasios Pogkas, Joanna Szkandera, Daniel Pink, and Dimosthenis Andreou. 2024. "What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor Entity" Cancers 16, no. 9: 1633. https://doi.org/10.3390/cancers16091633

Niethard, M., Knebel, C., Leithner, A., Tunn, P.-U., Schoon, J., Reichardt, P., Pogkas, A., Szkandera, J., Pink, D., & Andreou, D. (2024). What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor Entity. Cancers, 16(9), 1633. https://doi.org/10.3390/cancers16091633